Search company, investor...

Founded Year

2001

Stage

Acquired - II | Acquired

Valuation

$0000 

About CareFusion

CareFusion (NYSE: CFN) is a global corporation serving the healthcare industry with products and services that help hospitals improve the safety and quality of care. The company develops technologies including Alaris infusion pumps and IV sets, MaxPlus and MaxZero IV connectors and sets, Pyxis automated dispensing and patient identification systems, AVEA, LTV series and AirLife ventilation and respiratory products, ChloraPrep products, MedMined services for data mining surveillance, V. Mueller surgical instruments, and line of products that support interventional medicine. The company was founded in 2001 and is based in San Diego, California. In October 2014, CareFusion was acquired by BD at valuation of $12.2B.

Headquarters Location

3750 Torrey View Court

San Diego, California, 92130,

United States

888-876-4287

Loading...

Loading...

CareFusion Patents

CareFusion has filed 1409 patents.

The 3 most popular patent topics include:

  • fluid dynamics
  • medical equipment
  • dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/16/2020

2/20/2024

Fluid dynamics, Ion channels, Bones of the head and neck, Pumps, Integral membrane proteins

Grant

Application Date

1/16/2020

Grant Date

2/20/2024

Title

Related Topics

Fluid dynamics, Ion channels, Bones of the head and neck, Pumps, Integral membrane proteins

Status

Grant

Latest CareFusion News

Respiratory Care Devices Market Global Industry Analysis, Trends and Forecast Report to 2031, with Profiles for Philips Healthcare, Masimo, Fisher and Paykel Healthcare, ResMed, Covidien & CareFusion

Feb 19, 2024

The global respiratory care devices market is poised for substantial growth, with projections indicating an increase from US$ 20 billion in 2024 to a staggering US$ 40 billion by the end of 2031. Respiratory care devices play a pivotal role in the treatment, management, diagnosis, and care of patients with cardiopulmonary abnormalities. These devices are especially vital in addressing chronic obstructive pulmonary diseases (COPD), including chronic bronchitis and emphysema, which are leading causes of global mortality. The market is witnessing significant growth due to the rising incidence of chronic pulmonary obstructive diseases, technological innovations, and a robust product pipeline. Factors Driving Market Growth Rising Incidence of Chronic Pulmonary Obstructive Diseases: The increasing prevalence of chronic pulmonary obstructive diseases is primarily driven by changing lifestyles and environmental factors such as rising pollution levels. The introduction of novel products and a strong pipeline of respiratory care devices are expected to create lucrative opportunities in the market. Growing Geriatric Population Worldwide: The global geriatric population has been steadily increasing, with more than 2 billion individuals projected to be aged 60 and older by 2050, according to the World Health Organization (WHO). The elderly are more susceptible to respiratory diseases due to weakened immune systems, driving the demand for effective healthcare solutions tailored to this demographic. Challenges to Market Expansion Lack of Awareness in Developing Regions: Several developing regions have limited awareness of respiratory care devices and their benefits, hindering their adoption in these areas. Additionally, concerns regarding the potential adverse effects of these devices on neonates and excise taxes imposed by certain countries may limit sales growth. Regional Dominance North America is poised to dominate the global respiratory care devices market, followed by Europe. These regions benefit from highly developed healthcare infrastructures, a substantial patient pool affected by respiratory diseases due to lifestyle factors like tobacco use, and easy access to trained personnel proficient in operating advanced respiratory devices. Key Players Leading players in the global respiratory care devices market include Philips Healthcare (Netherlands), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), ResMed, Inc. (U.S.), Covidien plc (Ireland), and CareFusion Corporation (U.S.). Respiratory Care Devices Industry Research by Category By Product Type: 5.1.1.3. Monitoring Devices 5.2. Global Respiratory Care Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031 5.2.1. Key Highlights 5.2.1.2. Home Care 5.3. Global Respiratory Care Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031 6. North America Respiratory Care Devices Market Outlook, 2018 - 2031 7. Europe Respiratory Care Devices Market Outlook, 2018 - 2031 8. Asia Pacific Respiratory Care Devices Market Outlook, 2018 - 2031 9. Latin America Respiratory Care Devices Market Outlook, 2018 - 2031 10. Middle East & Africa Respiratory Care Devices Market Outlook, 2018 - 2031 11. Competitive Landscape 11.2. Company Market Share Analysis, 2023 11.3. Competitive Dashboard

CareFusion Frequently Asked Questions (FAQ)

  • When was CareFusion founded?

    CareFusion was founded in 2001.

  • Where is CareFusion's headquarters?

    CareFusion's headquarters is located at 3750 Torrey View Court, San Diego.

  • What is CareFusion's latest funding round?

    CareFusion's latest funding round is Acquired - II.

  • Who are the investors of CareFusion?

    Investors of CareFusion include Becton Dickinson and Cardinal Health.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.